One-off gene-editing therapy could permanently lower cholesterol: In an early-stage trial, a single dose of a CRISPR treatment lowered cholesterol levels, possibly permanently.
One-off gene-editing therapy could permanently lower cholesterol: In an early-stage trial, a single dose of a CRISPR treatment lowered cholesterol levels, possibly permanently.
www.managedhealthcareexecutive.com
Verve’s One-Time Gene Editor Cuts LDL by Nearly 70% in Early Trial
